Recordati, IT0003828271

Recordati stock: CVC investor tightens grip near EUR 53 bid

Published on 10/30/2026 at 10:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Recordati stock faces a more concentrated ownership structure after a CVC-linked buyer added shares. The tender offer remains central to minority investors.

CVC Extends Its Recordati Position

  • A CVC-linked investor increased its direct holding after buying shares on October 28.
  • Affiliated investors now control more than 62 percent of Recordati's share capital.
  • The tender offer continues to shape the outlook for minority shareholders and the stock's free float.
Recordati, IT0003828271, Illustration mit AI erstellt.

CVC-linked investors tightened their position in Recordati on Wednesday, October 28, 2026, by buying 691,106 shares at prices between 52.88 euros and 53.00 euros. TipRanks reported the transaction, which was carried out by CVC Capital Partners IX Aggregator SCA SICAV-RAIF Sub-Fund 2 in concert with Respighi BidCo.

CVC Builds Its Direct Stake

The purchase lifted the CVC investor's direct holding to 25,034,701 Recordati shares, equal to 11.97 percent of the company's share capital. The transaction was executed through J.P. Morgan Securities plc and remained at or below the increased tender offer consideration.

Other concert parties also hold substantial positions. Black Mountain holds 3.25 percent and Rossini holds 46.82 percent, according to the TipRanks report. Rossini's stake has already been tendered into the offer, leaving the affiliated investors with control of more than 62 percent of Recordati's share capital.

Offer Terms Set the Reference

Respighi BidCo is pursuing a voluntary tender offer for Recordati's ordinary shares. The 53.00-euro consideration gives the bid a clear reference point for shareholders assessing whether to tender, retain their shares or await further steps in the ownership process.

The growing concentration of shares strengthens the financial investors' influence over the Italian pharmaceutical group and reduces the portion of the company available to other market participants. For minority shareholders, the key issue is whether the tender process will lead to a more complete change in control and a smaller free float.

Recordati says it is a global pharmaceutical company listed on the Italian stock exchange, with more than 4,700 employees and operations in around 150 countries. Its business covers medicines for common diseases and rare conditions, while the tender offer adds a corporate-structure catalyst to the operating story. The company provides investor information through its investor relations page.

Recordati stock traded at 52.98 euros on Lang & Schwarz at 10:11 Berlin time on Friday, October 30, 2026; investors can follow the real-time quote of Recordati stock.

Recordati stock facts

  • Company: Recordati S.p.A.
  • ISIN: IT0003828271
  • Listing: Italian stock exchange
  • Lang & Schwarz quote: 52.98 euros at 10:11 Berlin time on October 30, 2026
  • Tender offer consideration: 53.00 euros per share
  • CVC direct holding: 11.97 percent after the October 28 purchase

The Italian equity market remains the relevant broader backdrop for Recordati investors; see current FTSE MIB market coverage.

Further developments around the tender offer and ownership structure will remain central to the investment case. Follow more news and analyses on Recordati stock.

Disclaimer...
en | IT0003828271 | RECORDATI | boerse | 70433555 |